BBWI Shareholder Action Reminder: Investors Urged to Review Rights Ahead of March 16, 2026 Deadline

New York, United States – A prominent securities law firm, Faruqi & Faruqi, LLP, has issued an important reminder to investors who purchased or acquired securities of Bath & Body Works, Inc. (NYSE: BBWI) during a specific period. The firm has highlighted the approaching March 16, 2026 deadline for investors to seek appointment as lead plaintiff in an ongoing federal securities class action lawsuit filed against the company.

The legal notice is part of an ongoing investigation into allegations that Bath & Body Works and certain executives may have violated federal securities laws by making misleading statements about the company’s business strategy, growth prospects, and financial performance. Investors who experienced significant financial losses may have the opportunity to participate in the class action and potentially recover damages.

Overview of the Securities Class Action Lawsuit

The securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Bath & Body Works securities between June 4, 2024 and November 19, 2025. During this period, plaintiffs claim that the company and its executives allegedly provided false or misleading information regarding the effectiveness of certain strategic initiatives designed to expand the company’s customer base and drive revenue growth.

According to the complaint, Bath & Body Works emphasized a strategy centered around “adjacencies, collaborations, and promotions”. This strategy involved expanding into additional product categories and engaging in brand partnerships to attract new customers and increase sales. However, the lawsuit alleges that these initiatives did not deliver the growth results that management had suggested publicly.

The lawsuit claims that despite knowing these strategies were underperforming, company leadership continued to present optimistic projections and positive statements about the company’s prospects. These statements allegedly caused the company’s stock price to remain artificially inflated, leading investors to purchase shares based on incomplete or misleading information.

Allegations of Misleading Statements and Strategic Failures

Expansion Strategy Under Scrutiny

The central allegation in the lawsuit revolves around Bath & Body Works’ expansion into new product categories, referred to internally as “adjacencies.” These categories included items such as men’s grooming products, lip care, hair products, and laundry-related items. Management promoted these categories as important drivers of growth.

However, according to the complaint, the expansion strategy ultimately failed to achieve the desired results. Rather than significantly expanding the customer base or boosting long-term revenue, the initiatives allegedly delivered weaker-than-expected outcomes.

Investors claim that management continued to portray the strategy as successful even as internal results suggested otherwise. The lawsuit argues that such communications created a misleading narrative about the company’s financial health and growth potential.

Reliance on Brand Collaborations

Another key allegation is that Bath & Body Works increasingly relied on short-term brand collaborations and promotional campaigns to maintain quarterly sales performance.

These collaborations were reportedly used to generate temporary spikes in sales, helping the company meet or approach quarterly expectations. Critics argue that this approach masked underlying weaknesses in the company’s core business performance.

By focusing heavily on promotional activities rather than sustainable growth strategies, the company may have delayed confronting deeper operational challenges.

Failure to Meet Financial Guidance

The lawsuit further alleges that Bath & Body Works was unlikely to meet the financial guidance it had previously provided to investors. Despite this, the company allegedly continued issuing positive statements regarding its outlook.

These statements, plaintiffs argue, lacked a reasonable factual basis because internal data already indicated that the company’s strategies were not delivering the expected results.

Financial Disclosures That Triggered the Stock Decline

Concerns surrounding Bath & Body Works intensified following the company’s announcement of disappointing financial results for the third quarter of 2025.

In November 2025, the company reported several troubling developments, including:

• A 1% year-over-year decline in revenue, missing earlier projections that anticipated growth.
• A significant 26% drop in net income, which fell to approximately $77 million.
• A downward revision of the company’s full-year earnings guidance.

Previously, Bath & Body Works had forecast earnings per share in the range of approximately $3.28 to $3.53. After the disappointing results were announced, the company reduced its expectations to around $2.83 per share or higher.

These announcements came alongside a significant strategic shift, as company leadership acknowledged that its previous focus on adjacencies and promotions had failed to significantly expand the overall customer base.

Major Stock Price Drop Following the Announcement

The market reacted strongly to the company’s revised financial outlook and strategic disclosures.

On November 20, 2025, after the company released its updated financial results and strategic assessment, Bath & Body Works shares fell dramatically. The stock price dropped approximately $5.22 per share, representing a decline of nearly 24.8% in a single trading day.

This sharp decline caused significant losses for investors who had purchased shares at higher prices during the alleged class period.

Many shareholders believe that had the true state of the company’s strategy and financial outlook been disclosed earlier, they might have made different investment decisions.

Role of the Lead Plaintiff in Securities Class Actions

In securities class action lawsuits, the lead plaintiff plays a critical role in representing the interests of all investors affected by the alleged misconduct.

The lead plaintiff is typically the investor who has suffered the largest financial loss and who is considered capable of adequately representing the class. Once appointed by the court, the lead plaintiff works with legal counsel to oversee the litigation and make key decisions regarding the case.

Importantly, investors who are part of the class do not need to serve as lead plaintiff to potentially recover damages. Those who choose not to pursue the leadership role can remain passive class members while still benefiting from any settlement or judgment.

Eligibility Requirements for Investors

Investors may be eligible to participate in the lawsuit if they purchased or acquired Bath & Body Works securities during the defined class period.

The criteria generally include:

• Purchasing or acquiring BBWI securities between June 4, 2024 and November 19, 2025.
• Suffering financial losses after the company’s stock price declined.
• Experiencing losses linked to the alleged misleading statements made by the company.

While investors with larger losses may be more likely to seek the lead plaintiff role, there is no minimum loss requirement for participation in the class action itself.

Faruqi & Faruqi LLP Encourages Investors to Take Action

Faruqi & Faruqi, LLP has encouraged investors who experienced significant losses in Bath & Body Works securities to contact the firm to discuss their legal options.

The firm’s securities litigation partner, James “Josh” Wilson, has urged investors to review their investment records and determine whether they may qualify to participate in the case.

The law firm has a long track record of representing investors in complex securities litigation. Since its founding in 1995, Faruqi & Faruqi has recovered hundreds of millions of dollars for shareholders harmed by corporate misconduct.

Importance of the March 16, 2026 Deadline

The most critical date for affected investors is the March 16, 2026 deadline. By this date, eligible investors must file a motion with the court if they wish to be considered for appointment as lead plaintiff.

Missing this deadline does not necessarily prevent investors from participating in the class action as members of the class. However, it does mean they will not be able to seek the leadership role in directing the litigation.

Because securities class actions often involve complex financial data and legal arguments, investors are typically encouraged to consult with experienced securities attorneys before making decisions about participation.

Whistleblowers and Additional Information Requests

In addition to contacting investors, Faruqi & Faruqi has also invited individuals with relevant information about Bath & Body Works’ internal operations to come forward.

This includes:

• Former employees of the company
• Current employees with knowledge of internal strategy discussions
• Industry experts familiar with the company’s business practices
• Shareholders who may possess relevant communications or documents

Information from such sources could potentially strengthen the legal claims being pursued in the class action lawsuit.

About Bath & Body Works, Inc.

Bath & Body Works is a well-known American retailer specializing in personal care products and home fragrance items. The company sells products including candles, lotions, soaps, perfumes, and seasonal fragrances through both physical retail stores and e-commerce platforms.

The brand has long been recognized for its strong customer loyalty and frequent product launches. However, like many retail companies, Bath & Body Works has faced challenges related to changing consumer preferences, competitive pressures, and evolving retail strategies.

The lawsuit now places additional scrutiny on the company’s strategic decisions and how those decisions were communicated to investors.

Potential Impact on Investors and the Retail Sector

Securities class actions such as the one involving Bath & Body Works can have broader implications for both investors and the corporate sector.

For investors, these cases serve as an important mechanism for holding publicly traded companies accountable when misleading information may have affected investment decisions.

For corporations, such lawsuits highlight the importance of maintaining transparency and accuracy in communications with shareholders. Companies are legally required to disclose material information that could influence investment decisions.

Failure to meet these obligations can result in legal consequences, regulatory scrutiny, and significant reputational damage.

Conclusion

The securities class action lawsuit against Bath & Body Works represents a significant development for investors who purchased shares during the alleged class period. With the March 16, 2026 deadline approaching, affected shareholders are encouraged to review their investment history and determine whether they wish to seek a leadership role in the litigation.

While the outcome of the case remains uncertain, the lawsuit underscores the importance of corporate transparency and investor protection within financial markets. As the case progresses, additional details regarding the allegations and potential damages may emerge.

Investors who believe they may have been affected are encouraged to seek legal guidance to fully understand their rights and available options.

#BBWI #BathAndBodyWorks #ShareholderRights #ClassActionLawsuit #SlimScan #GrowthStocks #CANSLIM